Chemomab Therapeutics Ltd. (NASDAQ:CMMB) Q1 2023 Earnings Call Transcript
Operator: Greetings, and welcome to Chemomab Therapeutics First Quarter 2023 Earnings Call and Corporate Update. At this time, all participants are in a listen-only-mode.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | ADAR1 Capital Management Daniel Schneeberger | 80,000 | $125,600 | 0.01% | |
| 2. | Citadel Investment Group Ken Griffin | 64,182 | $100,766 | -39% | 0% |
| 3. | Ikarian Capital Neil Shahrestani | 51,793 | $81,315 | 0.01% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.08 | 4,926 | $10,246.08 | 139,131 | 2026-05-29 | Filing | |
| $2.05 | 4,878 | $9,999.90 | 134,205 | 2026-05-29 | Filing | |
| $3.25 | 250 | $812.50 | 2,000 | 2022-03-16 | Filing | |
| $3.30 | 250 | $825.00 | 1,750 | 2022-03-16 | Filing | |
| $2.76 | 33 | $91.08 | 1,433 | 2022-05-24 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.51 | 70,524 | $318,063.24 | 2,241,274 | 2023-01-03 | Filing | |
| $3.34 | 266,376 | $889,695.84 | 2,311,798 | 2023-01-03 | Filing | |
| $5.03 | 6,100 | $30,663.48 | 251,147 | 2023-01-03 | Filing | |
| $5.03 | 7,700 | $38,706.36 | 317,075 | 2023-01-03 | Filing | |
| $2.00 | 2,409 | $4,818.00 | 10,000 | 2022-11-16 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 61,710 | $96,885 | 0% | |
| 2. | 18,629 | $29,248 | 0% | |
| 3. | 18,366 | $28,832 | 0% | |
| 4. | 14,566 | $22,869 | 0.01% | |
| 5. | 13,491 | $21,181 | 0% |